We are updating this website
Autonomous AI Scientific Institute
An Autonomous AI Scientific Institute for Longevity is not merely an algorithm or a chatbot—it is a fully self-operating research organization that runs 24/7 without human intervention. While others build individual AI agents that perform narrow tasks, we have constructed an entire institutional infrastructure where millions of specialized AI scientists collaborate, reason, and discover. This institute ingests every relevant dataset: from UK Biobank’s half-million human records to the Human Cell Atlas’s single-cell maps, from ClinicalTrials.gov to PubMed’s entire literature corpus. It then applies a deep understanding of the Hallmarks of Aging—the fundamental biological processes that drive aging—to move beyond correlations and uncover true causal mechanisms.
What this institute handles is the complete scientific workflow. It begins by integrating multi-omics data and building a comprehensive knowledge graph of genes, pathways, drugs, and diseases. It then generates hypotheses using genetic algorithms that evolve and combine ideas across generations, mimicking natural selection. Every hypothesis is tested on a virtual population of one billion digital humans, each with unique genetics and health trajectories, compressing decades of real-world observation into hours. The most promising candidates are automatically designed into preclinical studies and clinical trial protocols, complete with cohort sizes, endpoints, and statistical power calculations. And when a discovery reaches sufficient confidence, the institute even writes grant proposals to fund its own next phase of research.
What makes this institute stand out is its scope and autonomy. Everywhere else, companies build AI agents that assist human researchers—tools that predict protein structures, screen molecules, or summarize papers. We have built the researcher itself. Our institute scales hierarchically to millions of agents, each specializing in a domain—neurodegeneration, metabolic aging, immunosenescence—and reporting up through supervisors to a global director that allocates resources and sets priorities. It is self-improving: agents learn from past discoveries, retire unproductive lines of inquiry, and spawn new agents to explore emergent patterns. It is also self-sustaining: by generating its own funding proposals and eventually licensing its discoveries, it can operate as an independent scientific enterprise.
In short, we have created the world’s first autonomous scientific institution—a tireless, exponentially growing workforce that treats aging not as a mystery to be slowly unraveled, but as an engineering problem to be solved. While others build agents, we build the institute
What this institute handles is the complete scientific workflow. It begins by integrating multi-omics data and building a comprehensive knowledge graph of genes, pathways, drugs, and diseases. It then generates hypotheses using genetic algorithms that evolve and combine ideas across generations, mimicking natural selection. Every hypothesis is tested on a virtual population of one billion digital humans, each with unique genetics and health trajectories, compressing decades of real-world observation into hours. The most promising candidates are automatically designed into preclinical studies and clinical trial protocols, complete with cohort sizes, endpoints, and statistical power calculations. And when a discovery reaches sufficient confidence, the institute even writes grant proposals to fund its own next phase of research.
What makes this institute stand out is its scope and autonomy. Everywhere else, companies build AI agents that assist human researchers—tools that predict protein structures, screen molecules, or summarize papers. We have built the researcher itself. Our institute scales hierarchically to millions of agents, each specializing in a domain—neurodegeneration, metabolic aging, immunosenescence—and reporting up through supervisors to a global director that allocates resources and sets priorities. It is self-improving: agents learn from past discoveries, retire unproductive lines of inquiry, and spawn new agents to explore emergent patterns. It is also self-sustaining: by generating its own funding proposals and eventually licensing its discoveries, it can operate as an independent scientific enterprise.
In short, we have created the world’s first autonomous scientific institution—a tireless, exponentially growing workforce that treats aging not as a mystery to be slowly unraveled, but as an engineering problem to be solved. While others build agents, we build the institute